Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial VICCBMT1110

Title

Hematopoietic Stem Cell Transplantaion and Marrow Toxic Injuries (Registry)

Principal Investigator(s)

Stacey Goodman

Details

  • Protocol No. VICCBMT1110
  • Open Date: 11/02/2001
  • Staging: N/A
  • Age Group: Both Child and Adult
  • Scope: National
  • Objective: Collection of an extensive clinical data set on all stem cell transplant patients beginning with the diagnosis of the condition that is the transplant indication and continuing through the patient's life.
  • Disease Sites: Hematologic
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: NCT01166009
  • Secondary Protocol No: Not Specified

Description

None Provided.

Eligibility

Ages Eligible for Study:N/A and older
Genders Eligible for Study:Both
Accepts Healthy Volunteers:No

Criteria

Eligibility to Participate in the Research Database
Recipient Eligibility Criteria:
• Any recipient of an unrelated or related donor or autologous HSC transplant in a CIBMTR center is eligible to participate in the Research Database. This includes adults with and without decision making capacity, and children.
Individual with Marrow Toxic Injury Eligibility Criteria:
• Any individual who is treated for a marrow toxic injury at a center participating in the NMDP's Radiation Injury Transplant Network (RITN) is eligible to participate in the Research Database. This includes adults with and without decision making capacity, and children. Eligible individuals may have received supportive care only, growth factor support, HSC transplant or other appropriate medical treatment for marrow toxic injury. Treatments applied are at the discretion of the care facility, and are not determined by the NMDP or CIBMTR.
Unrelated Donor Eligibility Criteria:
• All donors registered on the NMDP Registry who have been requested to donate a product for a recipient are eligible to participate in the Research Database.
• All maternal cord blood donors are enrolled in the NMDP Cord Blood Bank Investigational New Drug (IND) protocol, and sign an informed consent document specific to that protocol. Data collected as part of the Cord Blood Bank protocol are included in the Research Database.